Riskpilot← Back to searchSign inGet full accessGerwelMed AB
ABActiveOrg 5593290686Kristoffer Huldts Väg 14General medical practice activities · NACE 8621Est. 20210 employees
Revenue 2024
SEK 1M
+7% vs 2023
EBITDA margin
13.4%
+23% vs 2023
Equity ratio
62.4%
Financial strength
Net profit 2024
SEK 117K
-32% vs 2023
| Revenue | SEK 1M | +7% |
| EBITDA | SEK 140K | +23% |
| Net profit | SEK 117K | -32% |
| Total assets | SEK 886K | +21% |
| Equity | SEK 553K | +27% |
| Employees | 0 | — |
Legal name
GerwelMed AB
Org number
5593290686
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
29 juli 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall sälja läkartjänster inom privat- och allmänsjukvård, huvudsakligen inom primärvården, men även BVC, skolhälsovården, äldrevården, den palliativa vården, företagshälsovården, den akuta sjukvården samt därmed förenlig verksamhet och därmed förenlig verksamhet.
Address
Kristoffer Huldts Väg 14
Email
annamed.ab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 309 | 1 226 | 981 | 1 048 |
| Staff expenses | — | — | — | −2 |
| EBITDA | 176 | 323 | 114 | 140 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 176 | 323 | 114 | 140 |
| Net financials | — | 0 | 3 | 7 |
| Profit before tax | 132 | 168 | 217 | 147 |
| Tax | −27 | −35 | −45 | −30 |
| Net profit | 105 | 133 | 172 | 117 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 406 | 677 | 731 | 886 |
| Equity | 130 | 263 | 435 | 553 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 232 | 414 | 295 | 333 |
| Total debt | 232 | 414 | 295 | 333 |
EBITDA margin
13.4%
This company
15.8%
Market median
-15% vs market
20212024
Equity ratio
62.4%
This company
38.2%
Market median
+63% vs market
20212024
Return on equity
21.2%
This company
18.4%
Market median
+15% vs market
20212024
Net profit margin
11.2%
This company
8.1%
Market median
+38% vs market
20212024
Asset turnover
1.18×
This company
1.12×
Market median
+5% vs market
20212024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-07-01 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
AnnaMed AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AnnaMed AB
GerwelMed AB Board members of GerwelMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Felicia Jasmine Fransson | Deputy Board Member | 0 companies |
| Anna Dorota Gaska-Dabrowska | Deputy Board Member | 0 companies |
| Agnieszka Grazyna Gerwel | Chairman | 0 companies |
| Lina Anna Elisabeth Nordström | Board of Directors | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Petra Maria Nilsson Andersson | Deputy Board Member | 0 companies |
| Mateusz Hirsz | Deputy Board Member | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Anna Halina Szymulska | Board of Directors | 0 companies |